U.S. Food and Drug Administration Senior Accountant Salaries in Gulfport-Biloxi, MS
The average U.S. Food and Drug Administration Senior Accountant in Gulfport-Biloxi, MS earns an estimated $94,416 annually, which includes an estimated base salary of $84,009 with a $10,407 bonus. U.S. Food and Drug Administration's Senior Accountant compensation is $6,077 more than the US average for a Senior Accountant. Senior Accountant salaries at U.S. Food and Drug Administration in Gulfport-Biloxi, MS can range from $49,920 - $185,000.
In Gulfport-Biloxi, MS, The Finance Department at U.S. Food and Drug Administration earns $18,181 more on average than the Customer Support Department.
Last updated 3 years ago.
- $84,009
- avg. base
- $10,407
- avg. bonus
Senior Accountant Salaries at U.S. Food and Drug Administration
In Gulfport-Biloxi, MS, Senior Accountants earn $1,871 more than Senior Accountants, and $20,979 less than Accounting Managers.
Compensation at U.S. Food and Drug Administration by Department
In Gulfport-Biloxi, MS, The Finance Department averages $18,181 more than the Customer Support Department, and $9,718 less than the Operations Department
Senior Accountant Compensation by Gender (All Companies)
The average female Senior Accountant at companies similar size to U.S. Food and Drug Administration reported making $84,874, while the average male Senior Accountant at similar sized companies reported making $97,131.
Senior Accountant Compensation by Ethnicity (All Companies)
The average Caucasian Senior Accountant at companies similar size to U.S. Food and Drug Administration reported making $91,995, while the average African American/Black Senior Accountant at similar sized companies reported making $66,666.
How Senior Accountants at U.S. Food and Drug Administration Rate Their Compensation
The majority of Senior Accountants at U.S. Food and Drug Administration believe they're compensated fairly. 100% of Senior Accountants at U.S. Food and Drug Administration say they receive annual bonuses, and the vast majority (71%) are satisfied with their benefits. See more compensation ratings at U.S. Food and Drug Administration
